KIROMIC BIOPHARMA INC reports a Return on Equity (ROE) of 213.70%.

What is KRBP's dividend yield?

KIROMIC BIOPHARMA INC offers a dividend yield of 0.00%.

What is KRBP's Deepscope Quality Score?

Deepscope rates KRBP's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy KRBP?

Deepscope's AI Timing Score for KRBP is 5 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does KRBP belong to?

KIROMIC BIOPHARMA INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu KRBP (NASDAQ) | KIROMIC BIOPHARMA INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-11 | FS: 2024-12-31)

KRBP

KIROMIC BIOPHARMA INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 65

USD 21.58

0.01 (0.06%) Day Change

Watchlist Portfolio Compare Chart

-1.14

D/E

213.7%

ROE

-314.8%

ROA

0.00%

Div Yield

KIROMIC BIOPHARMA INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 21.58 Price 0.01 (0.06%) Day Change	NEWS SCORE: 65

KRBP Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) và Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	65
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	21.58
PBV / Sector	-48.89 / 4.91
Earning Per Share	-1.03

PE / Sector	N/A / 18.34
PEG or PE/Growth / Sector	N/A / 0.61
Average 1M Daily Value	35.087625000000 GREAT
Average 1W Daily Value	17.334000000000 GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 468.85
NPM Average (%) / Sector	N/A / -1,531.69
NPM Change Average (%) / Sector	N/A / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-314.78 / 31.69
ROA Average (%) / Sector	-223.07 / -353.18
ROA Change Average (%) / Sector	105.63 / 5,214.65 GREAT
ROE (%) / Sector	213.70 / 10.58 GREAT
ROE Average (%) / Sector	253.61 / 27.64 GREAT
ROE Change Average (%) / Sector	-292.42 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.15

Chi tiết đăng ký

Analyze Date	2026-06-13 11:14:00
Symbol	KRBP
Name	KIROMIC BIOPHARMA INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	2.65 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	615.43 / 9,034.83

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 7707 Fannin Street, Houston, TX, United States, 77054

Phone: 832 968 4888

Website: https://www.kiromic.com

Sector: Healthcare >> Biotechnology

Description: Kiromic BioPharma, Inc., a clinical stage biotherapeutics company, engages in the utilization of non-engineered an engineered allogeneic Gamma Delta T (GDT) cell technologies to develop therapies for solid tumors in the United States. The company's lead product candidate is the Deltacel-01, which is in Phase 1 clinical trial, in combination with low-dose targeted radiation for patients with non-small cell lung cancer. It also develops Isocel, which is clinical trial in combination with low-dose radiation to treat Mesothelin Isoform 2 positive solid malignancies; Procel, which is in clinical trial in combination with low-dose radiation to treat PD-L1 positive solid malignancies; ALEXIS-ISO-1, which is in clinical trial to evaluate Isocel in patients with Mesothelin Isoform 2 positive solid malignancies; and ALEXIS-PRO-1, which is in clinical trial to evaluate Procel in patients with PD-L1 positive solid malignancies. It has a license agreement with Longwood University. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. On March 21, 2025, Kiromic BioPharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.